(Q36839725)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17547506%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

review article

1 reference

title

Chemokines and their receptors in respiratory disease: a therapeutic target for respiratory syncytial virus infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17547506%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17547506%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Mike Sharland

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17547506%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Lynette H Thomas

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17547506%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17547506%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Anti-infective Therapy

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17547506%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17547506%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17547506%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

415-425

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17547506%20AND%20SRC:MED&resulttype=core&format=json

Respiratory syncytial virus: the virus, the disease and the immune response

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Respiratory syncytial virus infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Respiratory syncytial virus infection in elderly and high-risk adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Impact of respiratory virus infections on persons with chronic underlying conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Exposure of neonates to respiratory syncytial virus is critical in determining subsequent airway response in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Pathological changes in virus infections of the lower respiratory tract in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Demonstration of Respiratory Syncytial Virus in an Autopsy Series

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Immune responses and disease enhancement during respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Respiratory syncytial virus and T cells: interplay between the virus and the host adaptive immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Differential chemokine expression following respiratory virus infection reflects Th1- or Th2-biased immunopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local TH2-like response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Chemokine receptors: multifaceted therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

The biology of chemokines and their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

CCR4 ligands are up-regulated in the airways of atopic asthmatics after segmental allergen challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

A role for MCP-1/CCR2 in interstitial lung disease in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Protection from pulmonary fibrosis in the absence of CCR2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Role of Eotaxin-1 (CCL11) and CC chemokine receptor 3 (CCR3) in bleomycin-induced lung injury and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

CC and C chemokine expression in pulmonary sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Chemokines and tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Transcriptional mechanisms regulating alveolar epithelial cell-specific CCL5 secretion in pulmonary tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: a role for CXCR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Non-redundant functional groups of chemokines operate in a coordinate manner during the inflammatory response in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Drug discovery: a historical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Chemokine receptor internalization and intracellular trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Role of Rho family GTPases in CCR1- and CCR5-induced actin reorganization in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Leucocyte chemotaxis: Examination of mitogen-activated protein kinase and phosphoinositide 3-kinase activation by Monocyte Chemoattractant Proteins-1, -2, -3 and -4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Interleukin-8 receptors R1 and R2 activate mitogen-activated protein kinases and induce c-fos, independent of Ras and Raf-1 in Chinese hamster ovary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

COPD: current therapeutic interventions and future approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Isoform-specific phosphoinositide 3-kinase inhibitors as therapeutic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

CCR5 antagonists: host-targeted antivirals for the treatment of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

The appealing story of HIV entry inhibitors : from discovery of biological mechanisms to drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

HIV co-receptors as targets for antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

A novel, selective, and orally available antagonist for CC chemokine receptor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Efficacy and safety of a monoclonal antibody recognizing interleukin-8 in COPD: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Chemokines and inflammation in the nasal passages of infants with respiratory syncytial virus bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Beta-chemokines, but neither T helper type 1 nor T helper type 2 cytokines, correlate with severity of illness during respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

RANTES (CCL5) production during primary respiratory syncytial virus infection exacerbates airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Role of CCL5 (RANTES) in viral lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

CC chemokine ligand 3 (CCL3) regulates CD8(+)-T-cell effector function and migration following viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

The future of respiratory syncytial virus vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Variants of the chemokine receptor CCR5 are associated with severe bronchiolitis caused by respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Predictions of CCR1 chemokine receptor structure and BX 471 antagonist binding followed by experimental validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

The human specific CCR1 antagonist CP-481,715 inhibits cell infiltration and inflammatory responses in human CCR1 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Role of CCL11 in eosinophilic lung disease during respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Respiratory syncytial virus G and/or SH glycoproteins modify CC and CXC chemokine mRNA expression in the BALB/c mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

T280M variation of the CX3C receptor gene is associated with increased risk for severe respiratory syncytial virus bronchiolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Role of fractalkine (CX3CL1) in regulating neuron-microglia interactions: development of viral-based CX3CR1 antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Respiratory syncytial virus infections in infants: Quantitation and duration of shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Functional antagonism of chemokine receptor CCR1 reduces mortality in acute pneumovirus infection in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Age- and infection-related maturation of the nasal immune response in 0-2-year-old children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.415

Immunoglobulin treatment for respiratory syncytial virus infection

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD004883.PUB2

Identifiers

DOI

10.1586/14787210.5.3.415

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17547506%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference